Naoya Yamazaki
0000-0002-9638-0428
16 papers found
Refreshing results…
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients
Real‐world efficacy and safety of BRAF‐targeted therapy for patients with advanced melanoma: A single‐center retrospective study in Japan
Long‐term survival with systemic therapy in the last decade: Can melanoma be cured?
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly
A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use
Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan
Merkel cell carcinoma: a review of clinical management with focus on Asian patients
Efficacy of chemotherapies for unresectable extramammary Paget disease: a single-centre retrospective study
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 ( J‐BASE‐MARGIN )
Efficacy of surgery for skin cancers initially suspected to be carcinoma of unknown primary: a retrospective observational study
Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review
Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study
Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study
Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption
Missing publications? Search for publications with a matching author name.